|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|---|
| Assets: | |||||
| Deferred offering costs | |||||
| Current Assets | |||||
| Cash | |||||
| Prepaid expenses | |||||
| Prepaid insurance | |||||
| Total Current Assets | |||||
| Long-term prepaid insurance | |||||
| Cash and securities held in Trust Account | |||||
| Total Assets | |||||
| Liabilities and Shareholders’ Deficit | |||||
| Current Liabilities | |||||
| Accrued expenses | |||||
| Accounts payable and accrued expenses | |||||
| Accrued offering costs | |||||
| Promissory note - related party | |||||
| Total Current Liabilities | |||||
| Deferred underwriting fee payable | |||||
| Total Liabilities | |||||
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 34,470,000 shares at redemption value of $10.34 and $10.07 per share as of September 30, 2026 and December 31, 2025, respectively | |||||
| Class A Ordinary Shares | |||||
| Total class A ordinary shares subject to possible redemption, $0.0001 par value; 34,470,000 shares at redemption value of $10.34 and $10.07 per share as of September 30, 2026 and December 31, 2025, respectively | |||||
| Shareholders’ Deficit | |||||
| Ordinary shares, value | |||||
| Additional paid-in capital | |||||
| Accumulated deficit | |||||
| Total Shareholders’ Deficit | |||||
| Total Liabilities and Shareholders’ Deficit |
Loading...